Bicocca Open Archive

Logo unimib boa
FAVERIO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.751
AS - Asia 8.881
EU - Europa 7.240
SA - Sud America 1.431
Continente sconosciuto - Info sul continente non disponibili 708
AF - Africa 238
OC - Oceania 30
Totale 33.279
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.010
SG - Singapore 3.050
IT - Italia 2.349
CN - Cina 1.661
VN - Vietnam 1.479
BR - Brasile 1.064
DE - Germania 1.041
HK - Hong Kong 1.029
RU - Federazione Russa 1.019
SE - Svezia 678
CA - Canada 543
IE - Irlanda 503
GB - Regno Unito 395
IN - India 301
FR - Francia 293
BD - Bangladesh 271
ID - Indonesia 220
FI - Finlandia 193
UA - Ucraina 127
JP - Giappone 122
AR - Argentina 120
AT - Austria 109
MX - Messico 105
ES - Italia 104
TR - Turchia 103
KR - Corea 98
IQ - Iraq 93
NL - Olanda 92
ZA - Sudafrica 86
PK - Pakistan 75
SA - Arabia Saudita 65
PL - Polonia 64
CO - Colombia 62
CH - Svizzera 60
PH - Filippine 51
EC - Ecuador 47
DK - Danimarca 41
BE - Belgio 40
UZ - Uzbekistan 38
MA - Marocco 32
CZ - Repubblica Ceca 30
PY - Paraguay 29
VE - Venezuela 28
AE - Emirati Arabi Uniti 26
CL - Cile 26
AU - Australia 25
KE - Kenya 24
PE - Perù 24
MY - Malesia 23
EG - Egitto 22
JM - Giamaica 22
TN - Tunisia 19
JO - Giordania 18
TH - Thailandia 18
LT - Lituania 17
PT - Portogallo 15
BO - Bolivia 14
ET - Etiopia 13
IL - Israele 13
UY - Uruguay 13
CR - Costa Rica 12
KZ - Kazakistan 12
IR - Iran 11
PS - Palestinian Territory 11
AZ - Azerbaigian 10
DO - Repubblica Dominicana 10
DZ - Algeria 10
LB - Libano 10
HN - Honduras 9
KG - Kirghizistan 9
NP - Nepal 9
RO - Romania 9
TW - Taiwan 9
AL - Albania 8
MN - Mongolia 8
SN - Senegal 8
BG - Bulgaria 7
NI - Nicaragua 7
PA - Panama 7
BY - Bielorussia 6
GR - Grecia 6
HU - Ungheria 6
OM - Oman 6
TT - Trinidad e Tobago 6
BB - Barbados 5
EE - Estonia 5
LK - Sri Lanka 5
NZ - Nuova Zelanda 5
RS - Serbia 5
HR - Croazia 4
KH - Cambogia 4
SC - Seychelles 4
SV - El Salvador 4
UG - Uganda 4
BH - Bahrain 3
CY - Cipro 3
GE - Georgia 3
MD - Moldavia 3
MM - Myanmar 3
PR - Porto Rico 3
Totale 32.521
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.176
Singapore 1.856
Ashburn 1.423
San Jose 1.169
Hong Kong 1.011
Milan 740
Fairfield 687
Chandler 678
Frankfurt am Main 645
Dublin 482
Ho Chi Minh City 449
Wilmington 424
New York 403
Santa Clara 375
Houston 374
Toronto 368
Hanoi 340
Dallas 320
Los Angeles 309
Woodbridge 307
Seattle 287
Chicago 283
Beijing 255
Cambridge 203
Hefei 187
Princeton 176
Jakarta 173
Council Bluffs 163
The Dalles 158
Dearborn 155
Rome 148
São Paulo 129
Helsinki 118
Shanghai 118
Buffalo 117
Lauterbourg 112
Columbus 110
Munich 110
Boardman 108
Jacksonville 87
Moscow 87
Altamura 86
Seoul 84
London 83
Lawrence 81
Nanjing 80
Orem 76
Vienna 74
Tokyo 73
Atlanta 59
Fremont 59
Guangzhou 58
San Diego 56
Da Nang 54
Montreal 54
Haiphong 53
Zurich 52
Brooklyn 49
Warsaw 48
Nuremberg 47
Johannesburg 45
Rio de Janeiro 45
Turin 44
Denver 43
Chennai 39
Phoenix 39
Stockholm 38
Dhaka 37
Brussels 35
Dong Ket 35
Figino 35
Mexico City 35
Monza 35
Turku 34
Tashkent 33
Boston 31
Lappeenranta 31
Biên Hòa 30
Poplar 29
Amsterdam 28
Baghdad 28
Bologna 28
Brasília 28
Jinan 28
Manchester 27
Hangzhou 26
Lissone 26
Naples 26
Salt Lake City 26
Ankara 25
Bắc Ninh 25
Riyadh 25
Belo Horizonte 24
New Delhi 24
Paris 24
Andover 23
Bogotá 23
Ha Long 23
Nanchang 23
Washington 23
Totale 20.272
Salva come PNG Salva come JPEG
Nome #
The ‘Liaisons dangereuses’ Between Lung Cancer and Interstitial Lung Diseases: A Focus on Acute Exacerbation 547
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 531
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 516
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 492
Impact of N-acetyl-L-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study 462
Progressive fibrosing interstitial lung diseases: prevalence and characterization in two Italian referral centers 459
Diagnostic delay in bronchiectasis: an Italian perspective 450
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 434
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 428
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study 418
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 415
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 403
Early referral to palliative care services in patients with IPF: A tool to take a step forward 399
A second update on mapping the human genetic architecture of COVID-19 392
Healthcare costs and resources utilization in children with difficult-to-control asthma treated with biologic therapies: A population-based cohort study 387
Mapping the human genetic architecture of COVID-19 370
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 365
Rehospitalization for pneumonia after first pneumonia admission: Incidence and predictors in a population-based cohort study 362
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 361
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 353
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 345
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 342
Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A single center experience and literature review 341
Idiopathic pulmonary fibrosis mortality in the Italian epicenter of COVID-19 pandemic 338
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 333
Clinical Characteristics of Anti-synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project 328
Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights 323
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 320
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 320
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 305
Impact of traffic-related air pollution on pulmonary oxidative stress 304
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 300
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 300
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study 299
Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy 297
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study 297
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 297
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients 296
Janus-faced amiodarone-induced pneumopathy 295
Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study 294
A 61-year-old female with chronic cough and purulent sputum 294
Allergic bronchopulmonary aspergillosis screening in bronchiectasis: Is there always a precise answer to a clear question? 286
Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study 284
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 284
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 283
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 283
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 279
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases 278
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 275
A multidisciplinary approach to screen the post-COVID-19 conditions 273
Phenotyping in Bronchiectasis: Are we moving towards a personalized medicine? 273
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study 270
The management of community-acquired pneumonia in the elderly 254
Molecular biomarkers in idiopathic pulmonary fibrosis: State of the art and future directions 254
Inpatient Care during the COVID-19 Pandemic: A Survey of Italian Physicians 253
Therapeutic Management of Bronchiectasis in Children and Adolescents: A Concise Narrative Review 252
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 250
Individualizing duration of antibiotic therapy in community-acquired pneumonia 249
History of lung volume reduction procedures 249
Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis 248
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 246
Feasibility and clinical impact of a portable bi-level ventilation device in patients with severe chronic obstructive pulmonary disease and exertional dyspnea: preliminary results from a clinical series 245
Hospital admission decision for patients with community-acquired pneumonia 244
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 244
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD 243
EBUS-TBNA nella patologia mediastino-polmonare: analisi retrospettiva dei primi 3 anni di attività di un singolo centro 243
Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre 241
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 234
Cardiovascular Structural and Functional Parameters in Idiopathic Pulmonary Fibrosis at Disease Diagnosis 232
Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis 227
Alteration of Lipid Metabolism in Patients with IPF and Its Association with Disease Severity and Prognosis: A Case–Control Study 226
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 226
Evaluation of preoperative cardiopulmonary reserve and surgical risk of patients undergoing lung cancer resection 225
Sleep-Disordered Breathing and Chronic Respiratory Infections: A Narrative Review in Adult and Pediatric Population 221
Systemic sclerosis and outcome in intensive care unit: Do not close the door, open the right protocol 221
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 221
Clinical differences in sarcoidosis patients with and without lymphoma: A single-centre retrospective cohort analysis 220
Long-term prognosis in community-acquired pneumonia 219
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach 216
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 215
Obstructive sleep apnea is associated with higher healthcare utilization in elderly patients 211
Idiopathic interstitial pneumonia in a patient with von Hippel-Lindau syndrome: a first case 207
Cystic lung in sarcoidosis: Clinico-radiologic characteristic and evolution 205
Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy 204
Clinical Impact of Vaping 204
Questionnaires May Help Pulmonologists for Referral of Patients With IPF to a Holistic Approach 200
Long-term macrolides in diffuse interstitial lung diseases 198
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers 197
Noninvasive ventilation for acute respiratory failure due to community-acquired pneumonia: A concise review and update 197
Increasing prevalence of chronic lung disease in veterans of the wars in Iraq and Afghanistan 197
Multidisciplinary approach to systemic diseases: benefits for diagnosis and management of complex disorders 194
Utility of precipitating antibody testing in the diagnostic evaluation of chronic hypersensitivity pneumonia 191
Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs 190
Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres 190
How do Climate Conditions and Urbanization Impact Non-Tuberculous Mycobacteria Infections? An Italian nationwide case-control study 190
Prevention of ventilator-associated pneumonia in the intensive care unit: a review of the clinically relevant recent advancements 190
The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases 189
Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients 184
Diagnostic Management of Pediatric Bronchiectasis: A Literature Review and Clinical Examples 184
Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function 182
Totale 28.702
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.884
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.626 0 193 230 174 100 159 75 122 74 98 134 267
2022/20232.658 278 694 307 232 191 386 44 185 170 27 82 62
2023/20241.960 54 74 123 100 239 452 339 96 121 52 39 271
2024/20255.505 300 557 293 261 431 334 375 234 564 888 510 758
2025/202614.456 1.882 827 998 1.575 1.572 722 2.010 659 1.168 1.141 756 1.146
2026/20271.134 660 474 0 0 0 0 0 0 0 0 0 0
Totale 33.279